Projected estimates of new cases and age-standardized incidence rates (excluding Quebec) for cancers by sex, Canada, 2022*
| Type of cancer | No. of new cases | ASIR† | ||||
|---|---|---|---|---|---|---|
| Total‡ | Males | Females | Both sexes | Males | Females | |
| All cancers§ | 233 900 | 121 100 | 112 800 | 514.0 | 555.4 | 483.3 |
| Lung and bronchus | 30 000 | 15 000 | 15 000 | 58.7 | 61.0 | 57.2 |
| Breast | 28 900 | 270 | 28 600 | 67.6 | 1.2 | 129.0 |
| Prostate | 24 600 | 24 600 | NA | NA | 117.8 | NA |
| Colorectal | 24 300 | 13 500 | 10 800 | 52.9 | 62.3 | 44.6 |
| Bladder | 13 300 | 10 000 | 3200 | 25.8 | 42.6 | 11.7 |
| Non-Hodgkin lymphoma | 11 400 | 6600 | 4800 | 25.6 | 31.4 | 20.6 |
| Melanoma | 9000 | 4900 | 4000 | 23.1 | 26.6 | 20.5 |
| Uterus (body, NOS) | 8100 | NA | 8100 | NA | NA | 36.8 |
| Kidney and renal pelvis | 8100 | 5400 | 2700 | 17.9 | 25.0 | 11.4 |
| Head and neck | 7500 | 5400 | 2000 | 16.3 | 24.6 | 8.7 |
| Pancreas | 6900 | 3800 | 3100 | 14.2 | 16.6 | 12.0 |
| Leukemia | 6700 | 4000 | 2700 | 15.4 | 19.4 | 11.9 |
| Thyroid | 6700 | 1850 | 4800 | 17.1 | 9.4 | 24.6 |
| Stomach | 4100 | 2600 | 1450 | 8.6 | 12.0 | 5.6 |
| Multiple myeloma | 4000 | 2400 | 1550 | 8.5 | 10.9 | 6.4 |
| Liver | 3500 | 2700 | 840 | 7.2 | 11.6 | 3.2 |
| Brain or CNS | 3200 | 1850 | 1350 | 7.2 | 8.7 | 5.7 |
| Ovary | 3000 | NA | 3000 | NA | NA | 13.4 |
| Esophagus | 2500 | 1900 | 580 | 5.5 | 9.0 | 2.4 |
| Cervix | 1450 | NA | 1450 | NA | NA | 7.5 |
| Testis | 1200 | 1200 | NA | NA | 6.6 | NA |
| Hodgkin lymphoma | 1050 | 600 | 460 | 2.6 | 2.9 | 2.3 |
| All other cancers | 24 500 | 12 400 | 12 100 | 51.0 | 55.7 | 47.6 |
Note: ASIR = age-standardized incidence rate, CNS = central nervous system, NA = not applicable, NOS = not otherwise specified.
↵* Rates are age standardized to the 2011 Canadian standard population. The complete definition of the specific cancers included here can be found in Appendix 1, Supplementary Table 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.212097/tab-related-content.
↵† Quebec is included in the cases because of its importance in determining the national total projected number. Quebec is excluded from the rates because a different projection method was used for this province than for other regions.
↵‡ Column totals may not sum to row totals due to rounding.
↵§ “All cancers” includes in situ bladder cancer and excludes nonmelanoma skin cancer (neoplasms, NOS; epithelial neoplasms, NOS; and basal and squamous).